会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明专利
    • Dentifrice composition
    • DENTIFRICE组成
    • JP2011051955A
    • 2011-03-17
    • JP2009204362
    • 2009-09-04
    • Lion Corpライオン株式会社
    • ISHIGURO KEIJI
    • A61K8/365A61K8/73A61Q11/00
    • PROBLEM TO BE SOLVED: To provide a dentifrice composition that has a convergence feeling derived from an organic acid or its salt and good moldability and is free from liquid separation after storage of a long period, less sticky and excellent in usability.
      SOLUTION: The dentifrice composition is characterized by including (A) an organic acid selected from gluconic acid, malic acid, tartaric acid and phytic acid and/or its salt, (B) xanthan gum, and (C) carboxymethylcellulose sodium, wherein the mass ratio of (B)/(A) is 0.3-2.0; the mass ratio of (C)/(B) is 0.2-5.0; and the pH at 25°C is 5.5-6.5. The dentifrice composition has a convergence feeling derived from an organic acid or its salt and good moldability, and is almost free from liquid separation after storage of a long period and less sticky. The dentifrice composition has a moderate convergence feeling suitable from the standpoints of matching with a flavor added to the dentifrice composition and giving a functional feeling and can be converted to a preparation making the best use of the convergence feeling.
      COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供一种具有从有机酸或其盐衍生的收敛感和良好的成型性的洁牙剂组合物,并且在长时间保存后不会发生液体分离,粘度低,使用性优异。 (A)选自葡萄糖酸,苹果酸,酒石酸和植酸和/或其盐的有机酸,(B)黄原胶和(C)羧甲基纤维素钠, (B)/(A)的质量比为0.3〜2.0; (C)/(B)的质量比为0.2-5.0; 25℃下的pH为5.5-6.5。 洁齿剂组合物具有从有机酸或其盐衍生的收敛感和良好的成型性,并且在长时间储存​​和较少粘稠之后几乎没有液体分离。 洁齿剂组合物具有适度的融合感,从与添加到洁齿剂组合物中的风味匹配的观点来看,具有功能感,并且可以转化为最佳利用收敛感的制剂。 版权所有(C)2011,JPO&INPIT
    • 3. 发明专利
    • Composition for oral cavity
    • 口腔组成
    • JP2010150155A
    • 2010-07-08
    • JP2008327815
    • 2008-12-24
    • Lion Corpライオン株式会社
    • ARAI MASAHITOHIRASAWA AYAKAUNO DAISUKEISHIGURO KEIJI
    • A61K8/35A61K8/34A61K8/44A61Q11/00
    • PROBLEM TO BE SOLVED: To provide a hinokitiol-containing composition for oral cavity, which is excellent in stability of hinokitiol in a preparation, exerts high antibacterial activity and suppresses discoloration or phase separation during long-term storage and is thus excellent in shelf stability. SOLUTION: The composition for oral cavity comprises: (a) hinokitiol; (b) at least one edetate chosen from disodium edetate, trisodium edetate, dipotassium edetate dihydrate and tetrasodium edetate dihydrate; (c) ethanol; and (d) water, provided that the contents of component (b) and component (c) are 0.02-1 mass% and 0.2-10 mass%, respectively, and the mass ratio of (d)/(c) is 3-200. COPYRIGHT: (C)2010,JPO&INPIT
    • 待解决的问题:为了提供在制剂中桧醇的稳定性优异的用于口腔的含桧醇的组合物,在长期保存中具有高抗菌活性和抑制变色或相分离,因此优异 货架稳定。 解决方案:口腔用组合物包含:(a)桧醇; (b)至少一种选自乙二胺四乙酸二钠,依地酸三钠,依地酸二钾二水合物和依地酸四钠二水合物的乙二胺四乙酸盐; (c)乙醇; 和(d)水,条件是组分(b)和组分(c)的含量分别为0.02-1质量%和0.2-10质量%,质量比(d)/(c)为3- 200。 版权所有(C)2010,JPO&INPIT
    • 5. 发明专利
    • MEDICINAL COMPOSITION
    • JP2000290200A
    • 2000-10-17
    • JP9695499
    • 1999-04-02
    • LION CORP
    • ISHIGURO KEIJIONIKI TAKAYUKI
    • A61K9/08A61K8/00A61K8/72A61K31/00A61K47/32A61P1/00A61P1/02A61Q11/00A61K7/00A61K7/16
    • PROBLEM TO BE SOLVED: To obtain an aqueous medicinal composition which possesses a specific range of gel transition temperature T, shows a liquid state at a temperature lower than T and a gel state at a temperature of T or above and exerts improved medicine retentivity in the diseased part by including a gel formable substance. SOLUTION: By including a gel formable substance (e.g. a polyvinylacetal diethylaminoacetate or the like), the aqueous medicinal composition which possesses gel transition temperature T (G) in a range of 5-40 deg.C and shows a liquid state at a temperature lower than the above T (G) and a gel state at a temperature of T (G) or above is obtained. The above gel formable substance is included in an amount capable of controlling the temperature T (G) in the above temperature range, preferably at 10-37 deg.C. For example, in the case of a polyvinyl acetal diethylamino-acetate, it is included in a proportion of 0.1-15 wt.%, preferably 0.1-15 wt.%, based on the composition. As the medicinal composition, the composition for oral cavity (particularly a peridontal disease therapeutic agent, a hyperesthesia therapeutic agent or a dental calculus suppressive agent) is preferably illustrated.